ROCKVILLE, MD — September 19, 2026 — The global cuffless BP monitor market is projected to increase from USD 1.1 billion in 2026 to USD 3.7 billion by 2036, expanding at a 12.9% CAGR, according to Fact.MR. The market reached approximately USD 974.3 million in 2025, reflecting increasing interest from device manufacturers, clinicians, home-monitoring users, and digital health platforms in technologies that enable blood pressure monitoring without an inflatable arm cuff.

The market is expected to create an absolute opportunity of USD 2.6 billion between 2026 and 2036. Growth is being supported by wider adoption of wearable health technologies, demand for more convenient hypertension monitoring, and the expansion of connected healthcare models.

Get detailed market forecasts, competitive benchmarking, and stem cell industry insights:https://www.factmr.com/connectus/sample?flag=S&rep_id=15735

PPG Technology Accounts for 43.8% Share

Photoplethysmography (PPG) is projected to account for 43.8% of the cuffless BP monitor market in 2026, making it the leading technology segment. Optical sensing is already established across many wearable health devices, providing manufacturers with an existing technology base for cuffless blood pressure measurement when combined with calibration methods and appropriate algorithms.

By device type, wearable blood pressure monitors are expected to hold 38.7% share in 2026. Wearable formats allow users to collect readings during everyday activities without repeatedly stopping for conventional cuff measurements.

Hospitals and clinics are forecast to account for 35.3% of market revenue in 2026, making them the leading end-user segment. Clinical settings remain important to the development and adoption of cuffless technologies because validation, calibration guidance, patient follow-up, and confidence in measurement data influence acceptance.

Online sales are projected to represent 35.1% share in 2026, supported by consumers comparing connected health devices, features, reviews, and app compatibility before purchase. Hypertension monitoring is expected to hold 35.0% share, reflecting the central role of blood pressure tracking in both clinical and personal health applications.

Wearable Monitoring Supports Market Expansion

The expansion of wearable health technology is one of the key factors supporting demand for cuffless BP monitoring. Users increasingly seek blood pressure trends without the inconvenience associated with repeated conventional cuff measurements.

PPG sensor adoption also provides manufacturers with a scalable technology base. However, the transition from convenience-focused wellness monitoring to clinically relevant blood pressure measurement depends on appropriate validation, calibration, and interpretation of readings.

Remote patient monitoring represents another area of opportunity. Connected devices can provide more frequent measurements that may be incorporated into digital healthcare workflows when appropriate validation and clinical protocols are established.

“Cuffless monitoring will be judged on confidence, not convenience alone. Device makers need to show how readings are calibrated, when users should confirm with a cuff and how clinicians can interpret the data,” said Shambhu Nath Jha, Sr. Consultant at Fact.MR.

Accuracy Validation Remains a Key Challenge

Despite strong growth projections, cuffless BP monitoring faces several adoption barriers. Accuracy validation remains a central concern, particularly when devices are intended for medical use or when readings could influence healthcare decisions.

Calibration requirements can also create friction for users expecting fully passive monitoring. Device manufacturers must communicate when calibration is required and how users should verify readings where appropriate.

Regulatory and clinical-review expectations may further increase development costs for products making medical-grade claims. Fact.MR identifies these requirements alongside accuracy concerns and calibration as important restraints on market expansion.

These challenges create opportunities for manufacturers that can provide clinically validated wearable models, clearer calibration procedures, and transparent guidance around appropriate use. Digital health platforms can also create value by converting frequent readings into understandable trends and alerts rather than presenting users with large volumes of raw data.

United States Records 16.7% CAGR

The United States cuffless BP monitor market is projected to expand at a 16.7% CAGR from 2026 to 2036. Remote patient monitoring, hypertension prevalence, wearable adoption, and online device sales are identified as factors supporting demand.

South Korea is projected to record a 13.8% CAGR, supported by consumer electronics adoption and interest in digital health. The United Kingdom is expected to grow at 12.9%, while Germany, Canada, Australia, and Japan are projected to register CAGRs of 12.5%, 12.3%, 12.2%, and 12.0%, respectively.

Market development varies by country as healthcare systems, wearable adoption, validation requirements, data considerations, and remote-care needs influence purchasing and clinical integration.

Competitive Landscape

Competition in the cuffless BP monitor market is shaped by measurement accuracy, calibration requirements, clinical validation, wearable design, and application usability.

Fact.MR identifies Aktiia SA (Hilo), Samsung Electronics Co., Ltd., and Biobeat Technologies Ltd. among the key companies profiled in the market. Aktiia and Biobeat offer dedicated cuffless blood pressure monitoring systems, while Samsung provides a blood pressure feature through Galaxy Watch devices that requires calibration using an upper-arm monitor.

As the market develops, manufacturers are expected to focus on strengthening validation evidence, improving sensor performance, refining wearable designs, and integrating blood pressure measurements with digital health platforms.

Report Scope

The Fact.MR Cuffless BP Monitor Market report covers cuffless blood pressure monitoring devices and related digital tools used for hypertension monitoring, home monitoring, clinical follow-up, and wearable health applications.

The study analyzes the market by technology, device type, end user, distribution channel, application, and region. Technologies covered include PPG, pulse transit time, ECG-PPG systems, applanation tonometry, ballistocardiography, and AI-based sensor fusion.

Device categories include wearable blood pressure monitors, smartwatches, fitness bands, handheld and portable monitors, patch-based monitors, smart rings, and ear-worn devices. The report covers North America, Latin America, Europe, East Asia, South Asia and Oceania, and the Middle East and Africa, with country-level analysis across 30+ countries.

Explore More Related Studies Published by Fact.MR Research:

Artificial Intelligence in Life Sciences Market- https://www.openpr.com/news/4633243/artificial-intelligence-in-life-sciences-market-to-reach-usd

Lumbar Spine Cages Market- https://www.openpr.com/news/4633244/lumbar-spine-cages-market-to-reach-usd-2-8-billion-by-2036-as

Medical and Pharmaceutical Dynamic Sealing Solutions Market- https://www.openpr.com/news/4633245/medical-pharmaceutical-dynamic-sealing-solutions-market

Medical Device CDMO Market- https://www.openpr.com/news/4633246/medical-device-cdmo-market-to-reach-usd-194-3-billion-by-2036-as

About Fact.MR

Fact.MR is a market research and consulting firm providing syndicated research, customized research, investment research, and market intelligence services across a broad range of industries. Its research coverage spans healthcare, consumer products, chemicals and materials, industrial automation, technology, packaging, and other industry sectors. Fact.MR provides market intelligence designed to help organizations understand market dynamics, emerging opportunities, competitive developments, and changing industry requirements.

Media Contact

Fact.MR
Email: sales@factmr.com
Website: www.factmr.com